Connecticut joins McKesson lawsuit
- Share via
Drug distributor McKesson Corp. artificially inflated drug prices for state-funded health programs, costing consumers millions of dollars, according to Connecticut Atty. Gen. Richard Blumenthal.
Blumenthal accused San Francisco-based McKesson of conspiring with Hearst Corp.’s First DataBank unit, a publisher of drug-price lists, to inflate the average wholesale prices for its pharmaceuticals. Connecticut joined California in suing McKesson after a federal court judge certified a class-action suit against the company in March.
“The allegations lack merit,” McKesson spokesman Larry Kurtz said. “We do not set average wholesale prices.”
More to Read
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
